PRLog (Press Release) -
Jul 08, 2010 -
Below are the top five companies in the Life Sciences Tools & Services industry as measured by beta. Lower-beta stocks mean minimal volatility and are therefore generally considered to be a less risk and offer more stable returns.
Cryo-Cell International (NASDAQ:CCEL)
ranks first with a beta of 0.4; NeoGenomics (NASDAQ:NGNM)
ranks second with a beta of 0.6; and Radient Pharmaceuticals (AMEX:RPC) ranks third with a beta of 0.7.
Techne (NASDAQ:TECH)
follows with a beta of 0.7 and QIAGEN (NASDAQ:QGEN)
rounds out the top five with a beta of 0.7.
SmarTrend is bearish on shares of QGEN and our subscribers were alerted to Sell on April 28, 2010 at $22.13. The stock has fallen 12.2% since the alert was issued.
About Cryo-Cell International, Inc. (OTCBB: CCEL.OB)
Based in Oldsmar, Florida, with nearly 200,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-
art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786-7235)
or visit
http://www.cryo-cell.com.
http://www.mysmartrend.com/news-briefs/news-watch/shares ...Umbilical cord blood stem cells: Stem cells from umbilical/Placental cord blood are to treat over 75 diseases & used in over 12,000 transplants worldwide. Cord blood Stem Cells Banking, Storage & preservation are very easy through our Private Cord blood banking at Cryo-Cell International, Inc.
